New insights into the functions of histidine-rich glycoprotein

International Review of Cell and Molecular Biology

Volumn 304, Issue , 2013, Pages 467-493

  Wakabayashi, Sadao ^a  

^a UNIVERSITY OF HYOGO   (Japan)

Author keywords

Angiogenesis; Blood coagulation; Fibrinolysis; Histidine rich glycoprotein; Insoluble immune complex

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BLOOD CLOTTING FACTOR 12; COMPLEMENT; FIBRINOGEN; GLYCOPROTEIN; HISTIDINE RICH GLYCOPROTEIN; IMMUNOGLOBULIN G; LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLASMINOGEN; UNCLASSIFIED DRUG; WORTMANNIN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; FIBRINOLYSIS; GENE STRUCTURE; HALF LIFE TIME; HUMAN; INNATE IMMUNITY; LIGAND BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; T LYMPHOCYTE; THROMBOCYTE;

MAMMALIA;

EID: 84879572877     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-407696-9.00009-9     Document Type: Chapter

References (111)

1. Angles-Cano E., Gris J.C., Loyau S., Schved J.F. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism. J. Lab. Clin. Med. 1993, 121:646-653.
2. Blank M., Shoenfeld Y. Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems. Clin. Rev. Allergy Immunol. 2008, 34:307-312.
3. Borza D.B., Tatum F.M., Morgan W.T. Domain structure and conformation of histidine-proline-rich glycoprotein. Biochemistry 1996, 35:1925-1934.
4. Burch M.K., Morgan W.T. Preferred heme binding sites of histidine-rich glycoprotein. Biochemistry 1985, 24:5919-5924.
5. Caccamo M.L., Rossi E., Salmoiraghi M.G., Mondonico P., Gianotti G.A., Marini A. The fibrinolytic system in the newborn: role of histidine-rich glycoprotein. Biol. Neonate 1992, 61:281-284.
6. Castaman G., Ruggeri M., Burei F., Rodeghiero F. High levels of histidine-rich glycoprotein and thrombotic diathesis. Report of two unrelated families. Thromb. Res. 1993, 69:297-305.
7. Chang N.S., Leu R.W., Rummage J.A., Anderson J.K., Mole J.E. Regulation of complement functional efficiency by histidine-rich glycoprotein. Blood 1992, 79:2973-2980.
8. Chang N.S., Leu R.W., Rummage J.A., Anderson J.K., Mole J.E. Regulation of macrophage Fc receptor expression and phagocytosis by histidine-rich glycoprotein. Immunology 1992, 77:532-538.
9. Corrigan J.J., Jeter M.A., Bruck D., Feinberg W.M. Histidine-rich glycoprotein levels in children: the effect of age. Thromb. Res. 1990, 59:681-686.
10. Dixelius J., Olsson A.K., Thulin A., Lee C., Johansson I., Claesson-Welsh L. Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein. Cancer Res. 2006, 66:2089-2097.
11. Engesser L., Kluft C., Briet E., Brommer E.J. Familial elevation of plasma histidine-rich glycoprotein in a family with thrombophilia. Br. J. Haematol. 1987, 67:355-358.
12. Fair D.S., Plow E.F. Synthesis and secretion of the fibrinolytic components, including alpha 2-antiplasmin, by a human hepatoma cell line. J. Lab. Clin. Med. 1983, 101:372-384.
13. Falkon L., Gari M., Montserrat I., Borrell M., Fontcuberta J. Familial elevation of plasma histidine-rich glycoprotein. A case associated with recurrent venous thrombosis and high PAI-1 levels. Thromb. Res. 1992, 66:265-270.
14. Gorgani N.N., Theofilopoulos A.N. Contribution of histidine-rich glycoprotein in clearance of immune complexes and apoptotic cells: implications for ameliorating autoimmune diseases. Autoimmunity 2007, 40:260-266.
15. Gorgani N.N., Parish C.R., Easterbrook Smith S.B., Altin J.G. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes. Biochemistry 1997, 36:6653-6662.
16. Gorgani N.N., Altin J.G., Parish C.R. Histidine-rich glycoprotein prevents the formation of insoluble immune complexes by rheumatoid factor. Immunology 1999, 98:456-463.
17. Gorgani N.N., Altin J.G., Parish C.R. Histidine-rich glycoprotein regulates the binding of monomeric IgG and immune complexes to monocytes. Int. Immunol. 1999, 11:1275-1282.
18. Gorgani N.N., Parish C.R., Altin J.G. Differential binding of histidine-rich glycoprotein (HRG) to human IgG subclasses and IgG molecules containing kappa and lambda light chains. J. Biol. Chem. 1999, 274:29633-29640.
19. Gorgani N.N., Smith B.A., Kono D.H., Theofilopoulos A.N. Histidine-rich glycoprotein binds to DNA and Fc gamma RI and potentiates the ingestion of apoptotic cells by macrophages. J. Immunol. 2002, 169:4745-4751.
20. Guan X., Juarez J.C., Qi X., Shipulina N.V., Shaw D.E., Morgan W.T., et al. Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells. Thromb. Haemost. 2004, 92:403-412.
21. Guthans S.A., Morgan W.T. The interaction of zinc, nickel and cadmium with serum albumin and histidine-rich glycoprotein assessed by equilibrium dialysis and immunoadsorbent chromatography. Arch. Biochem. Biophys. 1982, 218:320-328.
22. Hale J.S., Li M., Sinyuk M., Jahnen-Dechent W., Lathia J.D., Silverstein R.L. Context dependent role of the CD36-thrombospondin-histidine-rich glycoprotein axis in tumor angiogenesis and growth. PLoS One 2012, 7:e40033.
23. Haukkamaa M., Morgan W.T., Koskelo P. Serum histidine-rich glycoprotein during pregnancy and hormone treatment. Scand. J. Clin. Lab. Invest. 1983, 43:591-595.
24. Heimburger N., Haupt H., Kranz T., Baudner S. Human serum proteins with a high affinity for carboxymethylcellulose. II. Physico-chemical and immunological characterization of a histidine-rich 3,8S-α2-glycoprotein (CM-protein I). Hoppe Seylers Z. Physiol. Chem. 1972, 353:1133-1140.
25. Hennis B.C., DeMaat M.P.M., Quax P.H.A., Le Clercq E.J., Kuiper J., Kluft C. Evaluation of sites of synthesis of the histidine-rich glycoprotein. Thromb. Haemost. 1991, 65:884. Abstract 660.
26. Hennis B.C., Frants R.R., Bakker E., Vossen R.H., van der Poort E.W., Blonden L.A., et al. Evidence for the absence of intron H of the histidine-rich glycoprotein (HRG) gene: genetic mapping and in situ localization of HRG to chromosome 3q28-q29. Genomics 1994, 19:195-197.
27. Hennis B.C., Boomsma D.I., Fijnvandraat K., Gevers Leuven J.A., Peters M., Kluft C. Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent way. Thromb. Haemost. 1995, 73:484-487.
28. Hennis B.C., van Boheemen P.A., Wakabayashi S., Koide T., Hoffmann J.J., Kievit P., et al. Identification and genetic analysis of a common molecular variant of histidine-rich glycoprotein with a difference of 2kD in apparent molecular weight. Thromb. Haemost. 1995, 74:1491-1496.
29. Herrmann S., Poirier O., Nicaud V., Ruidavets J., Evans A., Arveiler D., et al. The histidine-rich glycoprotein Pro186/Ser polymorphism is not related to myocardial infarction in the ECTIM study. Thromb. Haemost. 1988, 79:359-361.
30. Hoffmann J.J., Hennis B.C., Kluft C., Vijgen M. Hereditary increase of plasma histidine-rich glycoprotein associated with abnormal heparin binding (HRG Eindhoven). Thromb. Haemost. 1993, 70:894-899.
31. Hutchens T.W., Yip T.T., Morgan W.T. Identification of histidine-rich glycoprotein in human colostrum and milk. Pediatr. Res. 1992, 31:239-246.
32. Jespersen J., Petersen K.R., Skouby S.O. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid. Am. J. Obstet. Gynecol. 1990, 163:396-403.
33. Jones A.L., Hulett M.D., Altin J.G., Hogg P., Parish C.R. Plasminogen is tethered with high affinity to the cell surface by the plasma protein, histidine-rich glycoprotein. J. Biol. Chem. 2004, 279:38267-38276.
34. 2+ chelation. J. Biol. Chem. 2004, 279:30114-30122.
35. Jones A.L., Hulett M.D., Parish C.R. Histidine-rich glycoprotein: a novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol. Cell Biol. 2005, 83:106-118.
36. Jones A.L., Poon I.K., Hulett M.D., Parish C.R. Histidine-rich glycoprotein specifically binds to necrotic cells via its amino-terminal domain and facilitates necrotic cell phagocytosis. J. Biol. Chem. 2005, 280:35733-35741.
37. Juarez J.C., Guan X., Shipulina N.V., Plunkett M.L., Parry G.C., Shaw D.E., et al. Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain. Cancer Res. 2002, 62:5344-5350.
38. Kazama Y., Koide T. Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein. Thromb. Haemost. 1992, 67:50-55.
39. Koide T. Human histidine-rich glycoprotein gene: evidence for evolutionary relatedness to cystatin supergene family. Thromb. Res. Suppl. 1988, 8:91-97.
40. Koide T., Fujimoto M. Visual evidence how histidine-rich glycoprotein promotes fibrinolysis. J. Thromb. Haemost. 2005, 3(Supplement 1). Abstract P0791.
41. Koide T., Kawate Y. Identification of plasminogen-binding site with which histidine-rich glycoprotein functions as an antifibrinolytic factor 1997.
42. Koide T., Odani S. Histidine-rich glycoprotein is evolutionarily related to the cystatin superfamily. Presence of two cystatin domains in the N-terminal region. FEBS Lett. 1987, 216:17-21.
43. Koide T., Odani S., Ono T. The N-terminal sequence of human plasma histidine-rich glycoprotein homologous to antithrombin with high affinity for heparin. FEBS Lett. 1982, 141:222-224.
44. Koide T., Foster D., Odani S. The heparin-binding site(s) of histidine-rich glycoprotein as suggested by sequence homology with antithrombin III. FEBS Lett. 1986, 194:242-244.
45. Koide T., Foster D., Yoshitake S., Davie E.W. Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA. Biochemistry 1986, 25:2220-2225.
46. Koide T., Kazama Y., Odani S., Hino H., Kato I. Analyses of heparin-binding domain by limited proteolysis and by monoclonal antibodies. Thromb. Haemost. 1989, 62:473. Abstract 1482.
47. Koide T., Izumi M., Ohashi T., Togo Y., Takahashi K., Hirokado Y., et al. Histidine-rich glycoproteins from human, bovine, and rat plasma: a remarkable diversity of primary structure among species and presence of two forms in rat plasma 1996.
48. Koide T., Fujimoto M., Ohshima T., Murase K. Identification of fibrinogen binding site of human histidine-rich glycoprotein (HRG) 2006, Abstract 155.
49. Koide T., Ohshima T., Takeuchi Y., Wakabayashi S. Fibrinogen interacts with histidine-rich glycoprotein (HRG) at the multiple sites 2008, Abstract P2-06.
50. Lamb-Wharton R.J., Morgan W.T. Induction of T-lymphocyte adhesion by histidine-proline-rich glycoprotein and concanavalin A. Cell. Immunol. 1993, 152:544-555.
51. Lane D.A., Pejler G., Flynn A.M., Thompson E.A., Lindahl U. Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4. J. Biol. Chem. 1986, 261:3980-3986.
52. Lerch P.G., Nydegger U.E., Kuyas C., Haeberli A. Histidine-rich glycoprotein binding to activated human platelets. Br. J. Haematol. 1988, 70:219-224.
53. Leung L.L. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J. Clin. Invest. 1986, 77:1305-1311.
54. Leung L.L., Harpel P.C., Nachman R.L., Rabellino E.M. Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood 1983, 62:1016-1021.
55. Leung L.L., Nachman R.L., Harpel P.C. Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J. Clin. Invest. 1984, 73:5-12.
56. Lijnen H.R., Hoylaerts M., Collen D. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. J. Biol. Chem. 1980, 255:10214-10222.
57. Lijnen H.R., DeCock F., Collen D. Turnover of human histidine-rich glycoprotein in healthy subjects and during thrombolytic therapy. Thromb. Res. 1981, 23:121-131.
58. Lijnen H.R., Jacobs G., Collen D. Histidine-rich glycoprotein in a normal and a clinical population. Thromb. Res. 1981, 22:519-523.
59. Lijnen H.R., Rylatt D.B., Collen D. Physicochemical, immunochemical and functional comparison of human histidine-rich glycoprotein and autorosette inhibition factor. Biochim. Biophys. Acta 1983, 742:109-115.
60. Lijnen H.R., van Hoef B., Collen D. Interaction of heparin with histidine-rich glycoprotein and with antithrombin III. Thromb. Haemost. 1983, 50:560-562.
61. MacQuarrie J.L., Stafford A.R., Yau J.W., Leslie B.A., Vu T.T., Fredenburgh J.C., et al. Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation. Blood 2011, 117:4134-4141.
62. Morgan W.T. Human serum histidine-rich glycoprotein. I. Interactions with heme, metal ions and organic ligands. Biochim. Biophys. Acta 1978, 535:319-333.
63. Morgan W.T. Interactions of the histidine-rich glycoprotein of serum with metals. Biochemistry 1981, 20:1054-1061.
64. Morgan W.T. The histidine-rich glycoprotein of serum has a domain rich in histidine, proline, and glycine that binds heme and metals. Biochemistry 1985, 24:1496-1501.
65. Morgan W.T. Serum histidine-rich glycoprotein levels are decreased in acquired immune deficiency syndrome and by steroid therapy. Biochem. Med. Metab. Biol. 1986, 36:210-213.
66. Morgan W.T., Koskelo P., Koenig H., Conway T.P. Human histidine-rich glycoprotein. II. Serum levels in adults, pregnant women and neonates. Proc. Soc. Exp. Biol. Med. 1978, 158:647-651.
67. Mori S., Takahashi H.K., Yamaoka K., Okamoto M., Nishibori M. High affinity binding of serum histidine-rich glycoprotein to nickel-nitrilotriacetic acid: the application to microquantification. Life Sci. 2003, 73:93-102.
68. Mosesson M.W. Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 2005, 3:1894-1904.
69. Muldbjerg M., Schousboe I., Halkier T. Purification of bovine histidine-rich glycoprotein. Thromb. Res. 1992, 65:815-819.
70. Nair P.S., Robinson W.E. Purification and characterization of a histidine-rich glycoprotein that binds cadmium from the blood plasma of the bivalve Mytilus edulis. Arch. Biochem. Biophys. 1999, 366:8-14.
71. Nordqvist S., Karehed K., Stavreus-Evers A., Akerud H. Histidine-rich glycoprotein polymorphism and pregnancy outcome: a pilot study. Reprod. Biomed. Online 2011, 23:213-219.
72. Ohta T., Ikemoto Y., Saeki K., Koide T., Wakabayashi S. Histidine-rich glycoprotein and concanavalin A synergistically stimulate the phosphatidylinositol 3-kinase-independent signaling pathway in leukocytes leading to increased cell adhesion and changes in cell morphology. Cell. Immunol. 2009, 259:5-12.
73. Ohta T., Ikemoto Y., Usami A., Koide T., Wakabayashi S. High affinity interaction between histidine-rich glycoprotein and the cell surface type ATP synthase on T-cells. Biochim. Biophys. Acta 2009, 1788:1099-1107.
74. Olsen H.M., Parish C.R., Altin J.G. Histidine-rich glycoprotein binding to T-cell lines and its effect on T-cell substratum adhesion is strongly potentiated by zinc. Immunology 1996, 88:198-206.
75. Omri A., Kruithof E.K., Bachmann F. Histidine-rich glycoprotein during pregnancy. Thromb. Haemost. 1988, 59:341.
76. Poon I.K., Olsson A.K., Hulett M.D., Parish C.R. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage. Biochem. J. 2009, 424:27-37.
77. Poon I.K., Hulett M.D., Parish C.R. Histidine-rich glycoprotein is a novel plasma pattern recognition molecule that recruits IgG to facilitate necrotic cell clearance via FcgammaRI on phagocytes. Blood 2010, 115:2473-2482.
78. Ranieri-Raggi M., Montali U., Ronca F., Sabbatini A., Brown P.E., Moir A.J.G., et al. Association of purified skeletal-muscle AMP deaminase with a hisitidine-proline-rich-glycoprotein-like molecule. Biochem. J. 1997, 326:641-648.
79. Ringvall M., Thulin A., Zhang L., Cedervall J., Tsuchida-Straeten N., Jahnen-Dechent W.W., et al. Enhanced platelet activation mediates the accelerated angiogenic switch, in mice lacking histidine-rich glycoprotein. PLoS One 2011, 6:e14526.
80. Rolny C., Mazzone M., Tugues S., Laoui D., Johansson I., Coulon C., et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 2011, 19:31-44.
81. Rydengard V., Olsson A.K., Morgelin M., Schmidtchen A. Histidine-rich glycoprotein exerts antibacterial activity. FEBS J. 2007, 274:377-389.
82. Rydengard V., Shannon O., Lundqvist K., Kacprzyk L., Chalupka A., Olsson A.K., et al. Histidine-rich glycoprotein protects from systemic Candida infection. PLoS Pathog. 2008, 4:e1000116.
83. Rylatt D.B., Sia D.Y., Mundy J.P., Parish C.R. Autorosette inhibition factor: isolation and properties of the human plasma protein. Eur. J. Biochem. 1981, 119:641-646.
84. Sabbatini A.R.M., Ranieri-Raggi M., Pollina L., Viacava P., Ashby J.R., Moir A.J.G., et al. Presence in human skeletal muscle of an AMP deaminase-associated protein that reacts with an antibody to human plasma histidine-proline-rich glycoprotein. J. Histochem. Cytochem. 1999, 47:255-260.
85. Sabbatini A.R., Mattii L., Battolla B., Polizzi E., Martini D., Ranieri-Raggi M., et al. Evidence that muscle cells do not express the histidine-rich glycoprotein associated with AMP deaminase but can internalise the plasma protein. Eur. J. Histochem. 2011, 55:e6.
86. Saez C.T., Jansen G.J., Smith A., Morgan W.T. Interaction of histidine-proline-rich glycoprotein with plasminogen: effect of ligands, pH, ionic strength, and chemical modification. Biochemistry 1995, 34:2496-2503.
87. Saigo K., Shatsky M., Levitt L.J., Leung L.K. Interaction of histidine-rich glycoprotein with human T lymphocytes. J. Biol. Chem. 1989, 264:8249-8253.
88. Saigo K., Yoshida A., Ryo R., Yamaguchi N., Leung L.L. Histidine-rich glycoprotein as a negative acute phase reactant. Am. J. Hematol. 1990, 34:149-150.
89. Saito H., Goodnough L.T., Boyle J.M., Heimburger N. Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis. Am. J. Med. 1982, 73:179-182.
90. Shannon O., Rydengard V., Schmidtchen A., Morgelin M., Alm P., Sorensen O.E., et al. Histidine-rich glycoprotein promotes bacterial entrapment in clots and decreases mortality in a mouse model of sepsis. Blood 2010, 116:2365-2372.
91. Shatsky M., Saigo K., Burdach S., Leung L.L., Levitt L.J. Histidine-rich glycoprotein blocks T cell rosette formation and modulates both T cell activation and immunoregulation. J. Biol. Chem. 1989, 264:8254-8259.
92. Shigekiyo T., Ohshima T., Oka H., Tomonari A., Azuma H., Saito S. Congenital histidine-rich glycoprotein deficiency. Thromb. Haemost. 1993, 70:263-265.
93. Shigekiyo T., Yoshida H., Matsumoto K., Azuma H., Wakabayashi S., Saito S., et al. HRG Tokushima: molecular and cellular characterization of histidine-rich glycoprotein. Blood 1998, 91:128-133.
94. Shigekiyo T., Yoshida H., Kanagawa Y., Satoh K., Wakabayashi S., Matsumoto T., et al. Histidine-rich glycoprotein (HRG) Tokushima 2: novel HRG deficiency, molecular and cellular characterization. Thromb. Haemost. 2000, 84:675-679.
95. Silverstein R.L., Febbraio M. CD36-TSP-HRGP interactions in the regulation of angiogenesis. Curr. Pharm. Des. 2007, 13:3559-3567.
96. Silverstein R.L., Leung L.L., Harpel P.C., Nachman R.L. Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. J. Clin. Invest. 1985, 75:2065-2073.
97. Silverstein R.L., Nachman R.L., Leung L.L., Harpel P.C. Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation. J. Biol. Chem. 1985, 260:10346-10352.
98. Simantov R., Febbraio M., Crombie R., Asch A.S., Nachman R.L., Silverstein R.L. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J. Clin. Invest. 2001, 107:45-52.
99. Souto J.C., Gari M., Falkon L., Fontcuberta J. A new case of hereditary histidine-rich glycoprotein deficiency with familial thrombophilia. Thromb. Haemost. 1996, 75:374-375.
100. 2+)-dependent activities of histidine-rich glycoprotein. Biochimie 2009, 91:1518-1522.
101. Thulin A., Ringvall M., Dimberg A., Karehed K., Vaisanen T., Vaisanen M.R., et al. Activated platelets provide a functional microenvironment for the antiangiogenic fragment of histidine-rich glycoprotein. Mol. Cancer Res. 2009, 7:1792-1802.
102. Tsuchida-Straeten N., Ensslen S., Schafer C., Woltje M., Denecke B., Moser M., et al. Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG). J. Thromb. Haemost. 2005, 3:865-872.
103. Tugues S., Honjo S., Konig C., Noguer O., Hedlund M., Botling J., et al. Genetic deficiency in plasma protein HRG enhances tumor growth and metastasis by exacerbating immune escape and vessel abnormalization. Cancer Res. 2012, 72:1953-1963.
104. 2+-dependent manner. J. Biol. Chem. 2006, 281:10298-10304.
105. Vestergaard A.B., Andersen H.F., Magnusson S., Halkier T. Histidine-rich glycoprotein inhibits contact activation of blood coagulation. Thromb. Res. 1990, 60:385-396.
106. Vu T.T., Stafford A.R., Leslie B.A., Kim P.Y., Fredenburgh J.C., Weitz J.I. Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain. J. Biol. Chem. 2011, 286:30314-30323.
107. Wakabayashi S., Takahashi K., Koide T. Structural characterization of the gene for human histidine-rich glycoprotein, reinvestigation of the 5'-terminal region of cDNA and a search for the liver specific promoter in the gene. J. Biochem. (Tokyo) 1999, 125:522-530.
108. Wakabayashi S., Yoshida H., Shigekiyo T., Koide T. Intracellular degradation of histidine-rich glycoprotein mutants: tokushima-1 and 2 mutants are degraded by different proteolytic systems. J. Biochem. (Tokyo) 2000, 128:201-206.
109. Wakabayashi S., Ioroi M., Maruyama K., Koide T. Amino acid sequence of chicken plasma histidine-rich glycoprotein 2001, P51 (in Japanese).
110. Yin Y., Huang J., Paine M.L., Reihold V.N., Chasteen N.D. Structural characterization of the major extrapallial fluid protein of the mollusc Mytilus edulis: implications for function. Biochemistry 2005, 44:10720-10731.
111. Yip T.T., Hutchens T.W. Metal ion affinity adsorption of a Zn(II)-transport protein present in maternal plasma during lactation: structural characterization and identification as histidine-rich glycoprotein. Protein Exp. Purif. 1991, 2:355-362.